Vericel (VCEL) Competitors $38.02 -1.34 (-3.40%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCEL vs. ROIV, LNTH, RVMD, BBIO, LEGN, TGTX, TLX, BPMC, SRPT, and AXSMShould you be buying Vericel stock or one of its competitors? The main competitors of Vericel include Roivant Sciences (ROIV), Lantheus (LNTH), Revolution Medicines (RVMD), BridgeBio Pharma (BBIO), Legend Biotech (LEGN), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry. Vericel vs. Roivant Sciences Lantheus Revolution Medicines BridgeBio Pharma Legend Biotech TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Blueprint Medicines Sarepta Therapeutics Axsome Therapeutics Roivant Sciences (NASDAQ:ROIV) and Vericel (NASDAQ:VCEL) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership, community ranking and analyst recommendations. Which has more volatility & risk, ROIV or VCEL? Roivant Sciences has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Vericel has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Does the MarketBeat Community believe in ROIV or VCEL? Vericel received 300 more outperform votes than Roivant Sciences when rated by MarketBeat users. However, 78.57% of users gave Roivant Sciences an outperform vote while only 61.85% of users gave Vericel an outperform vote. CompanyUnderperformOutperformRoivant SciencesOutperform Votes5578.57% Underperform Votes1521.43% VericelOutperform Votes35561.85% Underperform Votes21938.15% Does the media prefer ROIV or VCEL? In the previous week, Roivant Sciences had 10 more articles in the media than Vericel. MarketBeat recorded 17 mentions for Roivant Sciences and 7 mentions for Vericel. Vericel's average media sentiment score of 1.39 beat Roivant Sciences' score of 1.35 indicating that Vericel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Roivant Sciences 13 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Vericel 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in ROIV or VCEL? 64.8% of Roivant Sciences shares are owned by institutional investors. 7.9% of Roivant Sciences shares are owned by insiders. Comparatively, 5.2% of Vericel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer ROIV or VCEL? Roivant Sciences presently has a consensus price target of $17.50, indicating a potential upside of 54.27%. Vericel has a consensus price target of $60.86, indicating a potential upside of 57.93%. Given Vericel's higher possible upside, analysts clearly believe Vericel is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Vericel 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, ROIV or VCEL? Roivant Sciences has higher earnings, but lower revenue than Vericel. Roivant Sciences is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoivant Sciences$122.59M66.03$4.35B-$0.15-75.63Vericel$237.22M8.14-$3.18M$0.18214.08 Is ROIV or VCEL more profitable? Vericel has a net margin of 1.56% compared to Roivant Sciences' net margin of -119.54%. Vericel's return on equity of 1.48% beat Roivant Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Roivant Sciences-119.54% -14.05% -12.81% Vericel 1.56%1.48%0.96% SummaryVericel beats Roivant Sciences on 11 of the 18 factors compared between the two stocks. Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCEL vs. The Competition Export to ExcelMetricVericelBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.93B$2.95B$5.51B$7.66BDividend YieldN/A1.89%5.11%4.22%P/E Ratio641.8629.6422.3418.23Price / Sales8.14484.79391.77101.43Price / Cash3,081.95168.6838.1834.62Price / Book8.153.156.734.16Net Income-$3.18M-$72.17M$3.22B$248.05M7 Day Performance-3.78%-0.07%1.64%1.62%1 Month Performance-13.40%-3.32%-1.51%0.15%1 Year Performance-15.99%-23.11%16.82%4.01% Vericel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCELVericel2.2971 of 5 stars$38.02-3.4%$60.86+60.1%-15.7%$1.91B$237.22M633.77300News CoveragePositive NewsROIVRoivant Sciences2.164 of 5 stars$10.04-1.1%$17.50+74.3%+1.4%$7.16B$122.59M-66.93860Positive NewsLNTHLantheus3.9632 of 5 stars$100.62-0.7%$129.43+28.6%+54.6%$6.89B$1.53B16.74700Upcoming EarningsNews CoveragePositive NewsRVMDRevolution Medicines3.7504 of 5 stars$36.56-0.5%$66.67+82.3%+9.6%$6.80B$742,000.00-10.18250Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsBBIOBridgeBio Pharma4.5375 of 5 stars$33.51-1.1%$53.00+58.2%+43.0%$6.37B$221.90M-11.76400Earnings ReportAnalyst ForecastOptions VolumeNews CoverageGap UpLEGNLegend Biotech2.6211 of 5 stars$32.24-1.7%$79.00+145.0%-23.7%$5.92B$627.24M-33.941,070Positive NewsTGTXTG Therapeutics3.3312 of 5 stars$36.97-3.5%$40.67+10.0%+229.3%$5.81B$329.00M-369.66290Upcoming EarningsNews CoveragePositive NewsGap DownTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.21-3.0%$22.00+35.7%N/A$5.48B$783.21M0.00N/AAnalyst RevisionNews CoverageBPMCBlueprint Medicines2.5549 of 5 stars$84.18-0.6%$124.95+48.4%-5.0%$5.38B$508.82M-77.94640Upcoming EarningsAnalyst ForecastPositive NewsSRPTSarepta Therapeutics4.7287 of 5 stars$55.23+2.7%$158.70+187.3%-52.8%$5.36B$1.90B44.18840News CoveragePositive NewsAXSMAxsome Therapeutics4.8294 of 5 stars$103.00-1.4%$169.80+64.9%+49.2%$5.02B$385.69M-17.20380Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News Related Companies and Tools Related Companies ROIV Competitors LNTH Competitors RVMD Competitors BBIO Competitors LEGN Competitors TGTX Competitors TLX Competitors BPMC Competitors SRPT Competitors AXSM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCEL) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vericel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vericel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VCEL Stock Free VCEL Stock Alerts